Page last updated: 2024-09-05

paromomycin and Cardiomyopathy, Hypertrophic

paromomycin has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baruffini, E; Burlina, AB; Dallabona, C; Ferrero, I; Ghezzi, D; Haack, TB; Invernizzi, F; Meitinger, T; Melchionda, L; Parini, R; Prokisch, H; Strom, TM; Zeviani, M1

Other Studies

1 other study(ies) available for paromomycin and Cardiomyopathy, Hypertrophic

ArticleYear
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis.
    American journal of human genetics, 2012, Jun-08, Volume: 90, Issue:6

    Topics: Acidosis, Lactic; Base Sequence; Cardiomyopathy, Hypertrophic; Carrier Proteins; DNA Mutational Analysis; DNA, Mitochondrial; Fibroblasts; Homozygote; Humans; Mitochondria; Molecular Sequence Data; Mothers; Mutation; Mutation, Missense; Nucleic Acid Conformation; Oxidative Phosphorylation; Paromomycin; Phenotype; Phosphorylation; Respiration; RNA-Binding Proteins; RNA, Ribosomal; RNA, Transfer; Saccharomyces cerevisiae

2012